The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-(4-Bromophenyl)-3-(4-nitrophenyl)-4-(1,3-diphenyl-4,5-dihydro-1H-pyrazol-5-yl)pyrazole ID: ALA3416391
PubChem CID: 118734048
Max Phase: Preclinical
Molecular Formula: C30H22BrN5O2
Molecular Weight: 564.44
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=[N+]([O-])c1ccc(-c2nn(-c3ccc(Br)cc3)cc2C2CC(c3ccccc3)=NN2c2ccccc2)cc1
Standard InChI: InChI=1S/C30H22BrN5O2/c31-23-13-17-24(18-14-23)34-20-27(30(33-34)22-11-15-26(16-12-22)36(37)38)29-19-28(21-7-3-1-4-8-21)32-35(29)25-9-5-2-6-10-25/h1-18,20,29H,19H2
Standard InChI Key: BFCNZZJVMUPHNM-UHFFFAOYSA-N
Molfile:
RDKit 2D
38 43 0 0 0 0 0 0 0 0999 V2000
-1.1534 -1.8483 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4111 -3.6168 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0338 0.4429 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1553 -3.0401 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2296 3.2925 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.3397 -1.7522 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9886 -5.7908 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7593 2.9958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.6928 6.4199 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8397 -1.7033 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6544 4.0114 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9445 1.9884 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.7006 5.8646 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0331 -0.4449 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2611 3.4511 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8182 2.8545 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1890 -2.9886 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.4164 1.4790 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2568 -0.5878 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3316 -5.7715 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
-0.4653 -0.5154 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8177 -3.4768 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6669 -1.0635 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5242 0.2732 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6273 -2.5629 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.1560 -2.7955 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5871 1.5057 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4356 1.8185 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9511 0.8815 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8704 5.4907 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3274 -5.1145 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3431 -3.1106 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3278 3.0243 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.9165 4.3802 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7334 -4.9695 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6527 -1.9158 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.2994 -0.9050 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.2050 -2.9811 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19 29 1 0
17 6 2 0
33 16 2 0
1 32 2 0
6 10 1 0
28 3 2 0
10 14 1 0
28 33 1 0
27 29 1 0
22 35 1 0
16 18 1 0
10 4 2 0
25 23 1 0
25 17 1 0
11 30 2 0
7 31 1 0
11 15 1 0
34 13 1 0
13 9 2 0
12 29 1 0
9 30 1 0
6 19 1 0
5 8 2 0
31 20 1 0
31 2 2 0
32 4 1 0
19 23 2 0
21 1 1 0
24 3 1 0
12 28 1 0
25 22 1 0
8 27 1 0
8 11 1 0
35 7 2 0
12 5 1 0
18 24 2 0
22 26 2 0
14 21 2 0
15 34 2 0
2 26 1 0
36 37 2 0
36 38 1 0
1 36 1 0
M CHG 2 36 1 38 -1
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 564.44Molecular Weight (Monoisotopic): 563.0957AlogP: 7.57#Rotatable Bonds: 6Polar Surface Area: 76.56Molecular Species: NEUTRALHBA: 6HBD: ┄#RO5 Violations: 2HBA (Lipinski): 7HBD (Lipinski): ┄#RO5 Violations (Lipinski): 2CX Acidic pKa: ┄CX Basic pKa: 4.03CX LogP: 8.24CX LogD: 8.24Aromatic Rings: 5Heavy Atoms: 38QED Weighted: 0.16Np Likeness Score: -1.56
References 1. Bekhit AA, Hassan AM, Abd El Razik HA, El-Miligy MM, El-Agroudy EJ, Bekhit Ael-D.. (2015) New heterocyclic hybrids of pyrazole and its bioisosteres: design, synthesis and biological evaluation as dual acting antimalarial-antileishmanial agents., 94 [PMID:25768697 ] [10.1016/j.ejmech.2015.02.038 ]